Trial Profile
A Phase 1 Dose-Escalation Study of RRx-001 in Combination With Whole Brain Radiation in Subjects With Brain Metastases (BRAINSTORM)
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 08 Nov 2021
Price :
$35
*
At a glance
- Drugs Nibrozetone (Primary) ; Temozolomide
- Indications Brain metastases
- Focus Adverse reactions
- Acronyms BRAINSTORM
- Sponsors EpicentRx
- 01 Nov 2021 Status changed from active, no longer recruiting to completed.
- 21 Jul 2020 Planned End Date changed from 1 Jun 2020 to 1 Dec 2020.
- 31 May 2020 Results presented at the 56th Annual Meeting of the American Society of Clinical Oncology